CCR5 and neoplasm: Conclusively, our findings in this study suggest that CCR5-antagonist treatment may help to substantially improve the quality of life of HIV-infected patients and suggest a new therapeutic approach for preventing various bone-destructive diseases as well as arterial hypertension and anti-tumor immunity by blocking CCR563,64.